tiprankstipranks
Trending News
More News >
Promising Phase 3 Prospects and Strategic Study Design Justify Buy Rating for Chemomab Therapeutics
PremiumRatingsPromising Phase 3 Prospects and Strategic Study Design Justify Buy Rating for Chemomab Therapeutics
1M ago
Chemomab’s Nebokitug Shows Promising Phase 2 Results for PSC
Premium
Company Announcements
Chemomab’s Nebokitug Shows Promising Phase 2 Results for PSC
1M ago
Chemomab Therapeutics reports results in nebokitug Phase 2 PSC OLE trial
Premium
The Fly
Chemomab Therapeutics reports results in nebokitug Phase 2 PSC OLE trial
1M ago
Chemomab Therapeutics reports Q4 EPS (1c) vs. (1c) last year
PremiumThe FlyChemomab Therapeutics reports Q4 EPS (1c) vs. (1c) last year
2M ago
Chemomab Therapeutics sees cash runway through 1Q26
Premium
The Fly
Chemomab Therapeutics sees cash runway through 1Q26
2M ago
Chemomab Therapeutics price target raised to $7 from $4 at Maxim
Premium
The Fly
Chemomab Therapeutics price target raised to $7 from $4 at Maxim
2M ago
Chemomab’s Positive Trial Results Boost Investor Confidence
PremiumCompany AnnouncementsChemomab’s Positive Trial Results Boost Investor Confidence
6M ago
Chemomab Therapeutics reports Q3 EPS (1c) vs (2c) last year
Premium
The Fly
Chemomab Therapeutics reports Q3 EPS (1c) vs (2c) last year
6M ago
Chemomab Therapeutics sees cash runway through beginning of 2026
Premium
The Fly
Chemomab Therapeutics sees cash runway through beginning of 2026
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100